Professional Documents
Culture Documents
Non-toxic Toxic
2x
1x
Time of reaction
reduction
1
Hydrolysis of Aspirin
Hydrolysis of Procaine
E = plasma esterase H2N O C2H5
O
E Short-acting local
C O CH2 CH2 N
R – C – OR R - COOH + ROH anesthetic
acid alcohol C2H5
procaine
(novocaine)
E = plasma esterase
O
O
O C CH3 E OH
+ HO C CH3
COOH COOH
H2N O C2H5
aspirin salicylic acid acetic acid
C O + HO CH2 CH2 N
H
C2H5
Hydrolysis of Aspirin para-aminobenzoic diethylamino-
acid (PABA) ethanol
Procaine Hydrolysis
Amide Hydrolysis
Lidocaine Hydrolysis
Reduction of Chloral Hydrate
2
Overall Scheme of Oxidative Metabolism
P450-Dependent Drug Oxidation
NADP+ NADPH+
Non-specific system associated with ER
P 450 1- Substrate Binding
Multiple forms of CYP-P450 [enzyme] Flavoprotein
Reductase
Flavoprotein
(reduced) (oxidized)
1A2[12%] induced by Smoking and Charcoal Cooking 2 2- Substrate Reduction
2B6 [20%] induced by Phenobarbital (PB) and Rifampin e-
e-
3- Substrate Reduction
3
RH P -4 5 0 -F e 3 + O2
O2
H 2O
4- Substrate Rearrangement
Substrates: Oxygen, NADPH and Drug
1 4
P -4 5 0 -F e 3 +
R-H
(parent drug)
R-OH
(oxidized product) 4- Product Dissociation
NH2 NH2 O
Phase II reactions occur at reactive sites.
Desulfuratio
R1 R1
Thiopental. Phase II metabolites are usually inactive.
n
C S C O
R2 R2
3
Glucuronidation of Aspirin
Acetylation of Sulfanilamide
NH2 NH CO CH3
N - AT
+ HOOC CH3
UDPG is UDP-glucuronic acid
SA = salicylic acid
E is glucuronosyl transferase SO2NH2 SO2NH2
metabolite of aspir
Sulfanilamide Acetic Acid Acetylsulfanilamide
OH E OC6H9O6
COOH UDPG COOH N-AT is N-Acyltransferase
SA ether glucuronide of SA
10%
SA epinephrine metanephrine
(salicylic acid) glycine salicyluric acid
norepinephrine epinephrine
Acetaminophen Hepatotoxicity
ACETAMINOPHEN
HNCOCH3 HNCOCH3
PAPS UDPGA HNCOCH3
Factors Influencing Drug Metabolism I
SULFATE OH GLUCURONIDE Enzyme Induction (slow) increases drug clearance
45 - 50% P-450 MIXED FUNCTION OXIDASE
45 - 50%
HO-N-COCH3
Diseases: Hyperthyroidism
OXIDATIVE STRESS (•OH, O 2 •–)
4 - 5% POSTULATED
OH
LOW DOSE (1-2g)
TOXIC
INTERMEDIATES
Drugs [many]: PB, Rifmpin, Phenytoin, etc.
Key Factor NCOCH3 HIGH DOSE (10-15g)
GLUTATHIONE NUCLEOPHILIC CELL
MACROMOLECULES Conditions: smoking, alcoholism
1+
HNCOCH3 HNCOCH3
O
4
Factors Influencing Drug Metabolism II Factors Influencing Drug Metabolism III
Enzyme Inhibition (fast) reduces drug clearance Age: low metabolism in elderly and newborn
Diseases:Hypothyroidism, Liver Disease start low and go slow with drug dose
Conditions: Pregnancy, Aging, Newborn and charcoal cooked food and lower with high
Genetic Variations: